pargyline has been researched along with Kidney Diseases in 3 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaaya, R | 1 |
| Alfarano, C | 1 |
| Guilbeau-Frugier, C | 1 |
| Coatrieux, C | 1 |
| Kesteman, AS | 1 |
| Parini, A | 1 |
| Fares, N | 1 |
| Gue, M | 1 |
| Schanstra, JP | 1 |
| Bascands, JL | 1 |
| Nestor, G | 1 |
| Beroniade, V | 1 |
| Tutunaru, M | 1 |
| Onesti, G | 1 |
3 other studies available for pargyline and Kidney Diseases
| Article | Year |
|---|---|
Pargyline reduces renal damage associated with ischaemia-reperfusion and cyclosporin.
Topics: Animals; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; Kidney; Kidney Diseases; Ma | 2011 |
[Secondary effects of hypotensive drugs in arterial hypertension of renal origin].
Topics: Adult; Antihypertensive Agents; Female; Guanethidine; Humans; Hydralazine; Hypertension, Renal; Kidn | 1970 |
Renal pharmacodynamics of antihypertensive drugs: clinical applications.
Topics: Glomerular Filtration Rate; Guanethidine; Humans; Hydralazine; Hypertension; Kidney Diseases; Methyl | 1966 |